Jonathan Chang
Stock Analyst at Leerink Partners
(0)
# 4969
Out of 5,270 analysts
132
Total ratings
19.18%
Success rate
-33.82%
Average return
Main Sectors:
Top Industries:
| Name | Action | Price Target | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
Genmab | Upgrades: Outperform | 27 | 22.95 | 17.65% | 10 | Feb 13, 2025 | |
Vincerx Pharma | Maintains: Outperform | 80 40 | 0.77 | 5094.81% | 6 | Oct 8, 2024 | |
Immunocore Hldgs | Initiates Coverage On: Outperform | 74 | 28.89 | 156.14% | 1 | Apr 29, 2024 | |
Nanobiotix | Initiates Coverage On: Outperform | 11 | 3.54 | 210.73% | 1 | Dec 8, 2023 | |
NovoCure | Initiates Coverage On: Outperform | 51 | 18.36 | 177.78% | 1 | Aug 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Market Perform | 90 75 | 7.24 | 935.91% | 12 | Jan 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 30 34 | 12.1 | 180.99% | 9 | Dec 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Outperform | 6 | n/a | n/a | 1 | Nov 30, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Outperform | 14 | n/a | n/a | 1 | Nov 30, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Market Perform | 18 2 | n/a | n/a | 6 | Nov 15, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 100 40 | n/a | n/a | 6 | Nov 15, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Market Perform | 3 2 | n/a | n/a | 7 | Nov 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 48 50 | 10.5 | 376.19% | 4 | Aug 22, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 31 30 | 38.31 | -21.69% | 4 | Aug 10, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 15 12 | 2.29 | 424.02% | 8 | Aug 9, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Market Perform | 2 1 | n/a | n/a | 7 | Aug 9, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 13 14 | 0.49 | 2757.14% | 5 | Aug 9, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 25 26 | 4.2 | 519.05% | 5 | Jun 3, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 101 95 | 31.73 | 199.4% | 8 | May 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Market Perform | 20 60 | n/a | n/a | 5 | May 10, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Market Perform | 2 3 | 0.52 | 476.92% | 8 | May 9, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Market Perform | 5 4 | n/a | n/a | 5 | May 6, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 41 28 | 7.24 | 286.74% | 3 | Feb 25, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 57 53 | 14.44 | 267.04% | 7 | Aug 5, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Market Perform | 50 0 | n/a | n/a | 2 | May 10, 2018 |